[HTML][HTML] CD105 (Endoglin) as negative prognostic factor in AML
J Kauer, K Schwartz, C Tandler, C Hinterleitner… - Scientific reports, 2019 - nature.com
While several genetic and morphological markers are established and serve to guide
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
[引用][C] CD105 (Endoglin) as negative prognostic factor in AML
J Kauer, K Schwartz, C Tandler… - Scientific …, 2019 - tobias-lib.ub.uni-tuebingen.de
CD105 (Endoglin) as negative prognostic factor in AML CD105 (Endoglin) as negative
prognostic factor in AML DSpace Repositorium (Manakin basiert) Einloggen Publikationsdienste …
prognostic factor in AML DSpace Repositorium (Manakin basiert) Einloggen Publikationsdienste …
CD105 (Endoglin) as negative prognostic factor in AML
J Kauer, K Schwartz, C Tandler… - Scientific …, 2019 - ui.adsabs.harvard.edu
While several genetic and morphological markers are established and serve to guide
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
CD105 (Endoglin) as negative prognostic factor in AML.
J Kauer, K Schwartz, C Tandler… - Scientific …, 2019 - search.ebscohost.com
While several genetic and morphological markers are established and serve to guide
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
CD105 (Endoglin) as negative prognostic factor in AML.
J Kauer, K Schwartz, C Tandler, C Hinterleitner… - Scientific …, 2019 - europepmc.org
While several genetic and morphological markers are established and serve to guide
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
[引用][C] CD105 (Endoglin) as negative prognostic factor in AML
J Kauer, K Schwartz, C Tandler… - Scientific …, 2019 - ub01.uni-tuebingen.de
CD105 (Endoglin) as negative prognostic factor in AML CD105 (Endoglin) as negative
prognostic factor in AML DSpace Repositorium (Manakin basiert) Einloggen Publikationsdienste …
prognostic factor in AML DSpace Repositorium (Manakin basiert) Einloggen Publikationsdienste …
CD105 (Endoglin) as negative prognostic factor in AML
J Kauer, K Schwartz, C Tandler… - Scientific …, 2019 - pubmed.ncbi.nlm.nih.gov
While several genetic and morphological markers are established and serve to guide
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
[HTML][HTML] CD105 (Endoglin) as negative prognostic factor in AML
J Kauer, K Schwartz, C Tandler, C Hinterleitner… - Scientific …, 2019 - ncbi.nlm.nih.gov
While several genetic and morphological markers are established and serve to guide
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …
therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional …